Heng Lin

6.7k total citations · 1 hit paper
135 papers, 5.4k citations indexed

About

Heng Lin is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Heng Lin has authored 135 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 30 papers in Immunology and 29 papers in Epidemiology. Recurrent topics in Heng Lin's work include interferon and immune responses (14 papers), MicroRNA in disease regulation (12 papers) and Autophagy in Disease and Therapy (12 papers). Heng Lin is often cited by papers focused on interferon and immune responses (14 papers), MicroRNA in disease regulation (12 papers) and Autophagy in Disease and Therapy (12 papers). Heng Lin collaborates with scholars based in Taiwan, China and United States. Heng Lin's co-authors include Ching‐Feng Cheng, Hui‐Chen Ku, Hong‐Bing Shu, Ming‐Ming Hu, Fang Hua, Hsi-Hsien Chen, Zhi Chen, Hsiao‐Fen Li, Huan Liu and Pei‐Fang Lai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Heng Lin

132 papers receiving 5.3k citations

Hit Papers

PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Lin Taiwan 43 2.9k 1.2k 1.1k 920 609 135 5.4k
Alejandro Zentella‐Dehesa Mexico 32 3.3k 1.1× 1.6k 1.4× 833 0.8× 683 0.7× 498 0.8× 140 6.7k
Rafał Pawliński United States 40 2.2k 0.7× 1.8k 1.5× 711 0.7× 1.2k 1.3× 490 0.8× 103 6.7k
Mingui Fu United States 43 3.1k 1.1× 1.6k 1.3× 708 0.7× 1.2k 1.3× 658 1.1× 101 5.5k
David J. Granville Canada 48 2.3k 0.8× 1.5k 1.2× 686 0.6× 689 0.7× 400 0.7× 146 6.3k
Martin Bilban Austria 49 4.8k 1.6× 2.1k 1.7× 839 0.8× 973 1.1× 662 1.1× 143 8.4k
Ana L. Mora United States 46 2.1k 0.7× 1.8k 1.4× 890 0.8× 991 1.1× 777 1.3× 125 7.8k
Xiao‐Ming Yin United States 38 3.7k 1.3× 695 0.6× 1.6k 1.5× 646 0.7× 348 0.6× 122 6.3k
Jelena Mann United Kingdom 36 2.0k 0.7× 913 0.8× 1.5k 1.4× 692 0.8× 1.1k 1.7× 65 5.0k
Małgorzata Wygrecka Germany 41 1.6k 0.6× 970 0.8× 461 0.4× 578 0.6× 315 0.5× 127 4.9k
Shuichi Kaneko Japan 42 3.2k 1.1× 760 0.6× 2.3k 2.1× 1.1k 1.2× 1.0k 1.6× 191 7.1k

Countries citing papers authored by Heng Lin

Since Specialization
Citations

This map shows the geographic impact of Heng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Lin more than expected).

Fields of papers citing papers by Heng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Lin. The network helps show where Heng Lin may publish in the future.

Co-authorship network of co-authors of Heng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Lin. A scholar is included among the top collaborators of Heng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Lin. Heng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Wei‐Jan, et al.. (2023). New Synthesized Activating Transcription Factor 3 Inducer SW20.1 Suppresses Resistin-Induced Metabolic Syndrome. Biomedicines. 11(6). 1509–1509. 1 indexed citations
3.
Wu, Yueh-Lin, et al.. (2022). Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders. International Journal of Molecular Sciences. 23(3). 1032–1032. 17 indexed citations
4.
Lin, Heng, Yen‐Sung Huang, Jean‐Michel Fustin, et al.. (2021). Hyperpolyploidization of hepatocyte initiates preneoplastic lesion formation in the liver. Nature Communications. 12(1). 645–645. 38 indexed citations
5.
Lin, Heng, Maoping Tang, Changyi Ji, et al.. (2021). BAG3 Regulation of RAB35 Mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome Pathway and Tau Clearance. Biological Psychiatry. 92(1). 10–24. 11 indexed citations
6.
Mei, Qian, et al.. (2020). CUL4A promotes the invasion of cervical cancer cells by regulating NF-κB signaling pathway. SHILAP Revista de lepidopterología. 4 indexed citations
7.
Wu, Yueh-Lin, Hsiao‐Fen Li, Hsi-Hsien Chen, & Heng Lin. (2020). MicroRNAs as Biomarkers and Therapeutic Targets in Inflammation- and Ischemia-Reperfusion-Related Acute Renal Injury. International Journal of Molecular Sciences. 21(18). 6738–6738. 33 indexed citations
8.
Chao, Hsu‐Wen, Shi-Wei Chao, Heng Lin, Hui‐Chen Ku, & Ching‐Feng Cheng. (2019). Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 20(2). 298–298. 134 indexed citations
9.
Liao, Wei‐Ju, Heng Lin, Ching‐Feng Cheng, et al.. (2018). SCUBE1-enhanced bone morphogenetic protein signaling protects against renal ischemia-reperfusion injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(2). 329–338. 7 indexed citations
10.
Lin, Heng, et al.. (2016). Extraembryonic but not embryonic SUMO-specific protease 2 is required for heart development. Scientific Reports. 6(1). 20999–20999. 28 indexed citations
11.
Hu, Ming‐Ming, Qing Yang, Xueqin Xie, et al.. (2016). Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus. Immunity. 45(3). 555–569. 305 indexed citations
12.
Yu, Jinmei, Wei Sun, Fang Hua, et al.. (2015). BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. Cancer Letters. 365(2). 190–200. 77 indexed citations
13.
Lin, Heng, Huan Liu, Qin Sun, et al.. (2013). KLF4 promoted odontoblastic differentiation of mouse dental papilla cells via regulation of DMP1. Journal of Cellular Physiology. 228(10). 2076–2085. 40 indexed citations
14.
Sun, Wei, Heng Lin, Hua Fang, & Zhuowei Hu. (2013). [Optimizing the host bacteria to make a large naive phage antibody library in the recombination system].. PubMed. 48(1). 66–70. 1 indexed citations
15.
Sun, Qin, Huan Liu, Heng Lin, et al.. (2013). MicroRNA-338-3p promotes differentiation of mDPC6T into odontoblast-like cells by targeting Runx2. Molecular and Cellular Biochemistry. 377(1-2). 143–149. 29 indexed citations
16.
Lv, Qi, Wei Wang, Jianfei Xue, et al.. (2012). DEDD Interacts with PI3KC3 to Activate Autophagy and Attenuate Epithelial–Mesenchymal Transition in Human Breast Cancer. Cancer Research. 72(13). 3238–3250. 141 indexed citations
17.
Lin, Heng, Fang Hua, & Zhuowei Hu. (2012). Autophagic flux, supported by toll-like receptor 2 activity, defends against the carcinogenesis of hepatocellular carcinoma. Autophagy. 8(12). 1859–1861. 25 indexed citations
18.
Lin, Heng, Lili Xu, Huan Liu, et al.. (2011). KLF4 Promotes the Odontoblastic Differentiation of Human Dental Pulp Cells. Journal of Endodontics. 37(7). 948–954. 55 indexed citations
19.
Cheng, Ching‐Feng, Wei‐Shiung Lian, Chun‐Yi Lu, et al.. (2008). Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis. APOPTOSIS. 13(7). 883–894. 54 indexed citations
20.
Chen, Chun‐Chi, Chun‐Cheng Hou, Yuh‐Mou Sue, et al.. (2007). Prostacyclin protects renal tubular cells from gentamicin-induced apoptosis via a PPARα-dependent pathway. Kidney International. 73(5). 578–587. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026